Subscribe To
ARDS / Aridis Pharmaceuticals Stock (ARDS): Why The Price Surged Up Today
ARDS News
By Zacks Investment Research
July 13, 2023
Aridis (ARDS) Up on Receiving FDA's QIDP Designation for AR-301
Aridis (ARDS) achieves a milestone as the FDA granted the Qualified Infectious Disease Product designation for AR-301. more_horizontal
By Zacks Investment Research
June 21, 2023
Aridis (ARDS) Up on Regulatory Update for Pneumonia Drug
Aridis (ARDS) announces that its AR-301 clinical program is eligible for availing the FDA's special pathway for satisfying the unmet medical need of a more_horizontal
By Zacks Investment Research
June 1, 2023
Aridis (ARDS) Up After FDA Nod for Pneumonia Drug Study Design
Aridis (ARDS) stock jumps 115% after the company reports reaching an agreement with the FDA on its proposed study on AR-301 as an adjunctive treatment more_horizontal
By PennyStocks
May 31, 2023
5 Hot Penny Stocks To Watch With Big News This Week
Whether you're trading penny stocks or higher-priced company shares, everyone wants to gain an edge. In the stock market today, there are plenty of ca more_horizontal
By Zacks Investment Research
March 14, 2023
Aridis (ARDS) Stock Up as Cystic Fibrosis Study Meets Goals
Aridis Pharmaceuticals (ADRS) meets primary and secondary endpoints in a phase IIa study on AR-501 for treating cystic fibrosis. more_horizontal
By Zacks Investment Research
November 21, 2022
Aridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -4,100% and 96.44%, respectively, for the quarter ended September 2022. Do t more_horizontal
By Pulse2
January 27, 2022
Aridis Pharmaceuticals Stock (ARDS): Why The Price Surged Up Today
The stock price of Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) increased by over 30% during intraday trading today. This is why it happened. more_horizontal
By Pulse2
January 27, 2022
Aridis Pharmaceuticals Stock (ARDS): Why The Price Surged Up Today
The stock price of Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) increased by over 30% during intraday trading today. This is why it happened. more_horizontal